The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pain Management Drugs & Devices Market Research Report 2024
Synopsis
The global Pain Management Drugs & Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Pain Management Drugs & Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management Drugs & Devices.
Report Scope
The Pain Management Drugs & Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Management Drugs & Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Management Drugs & Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie Inc.
Astrazeneca Depomed Inc.
Djo Global Inc.
Eli Lilly & Co.
Endo International
Glaxosmithkline
Hisamitsu Pharmaceutical Co. Inc.
Johnson & Johnson
Medtronic Inc.
Novartis International Ag
Pfizer
Purdue Pharmaceuticals Lp
Abbott
Segment by Type
Pharmaceuticals
Devices
Segment by Application
Burn Pain
Cancer Pain
Dental/Facial Pain
Migraine Headache Pain
Musculoskeletal Pain
Neuropathic Pain
Obstetrical Pain
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pain Management Drugs & Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pain Management Drugs & Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pain Management Drugs & Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Pain Management Drugs & Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management Drugs & Devices.
Report Scope
The Pain Management Drugs & Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Management Drugs & Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Management Drugs & Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie Inc.
Astrazeneca Depomed Inc.
Djo Global Inc.
Eli Lilly & Co.
Endo International
Glaxosmithkline
Hisamitsu Pharmaceutical Co. Inc.
Johnson & Johnson
Medtronic Inc.
Novartis International Ag
Pfizer
Purdue Pharmaceuticals Lp
Abbott
Segment by Type
Pharmaceuticals
Devices
Segment by Application
Burn Pain
Cancer Pain
Dental/Facial Pain
Migraine Headache Pain
Musculoskeletal Pain
Neuropathic Pain
Obstetrical Pain
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pain Management Drugs & Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pain Management Drugs & Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pain Management Drugs & Devices Market Overview
1.1 Product Overview and Scope of Pain Management Drugs & Devices
1.2 Pain Management Drugs & Devices Segment by Type
1.2.1 Global Pain Management Drugs & Devices Market Value Comparison by Type (2024-2030)
1.2.2 Pharmaceuticals
1.2.3 Devices
1.3 Pain Management Drugs & Devices Segment by Application
1.3.1 Global Pain Management Drugs & Devices Market Value by Application: (2024-2030)
1.3.2 Burn Pain
1.3.3 Cancer Pain
1.3.4 Dental/Facial Pain
1.3.5 Migraine Headache Pain
1.3.6 Musculoskeletal Pain
1.3.7 Neuropathic Pain
1.3.8 Obstetrical Pain
1.4 Global Pain Management Drugs & Devices Market Size Estimates and Forecasts
1.4.1 Global Pain Management Drugs & Devices Revenue 2019-2030
1.4.2 Global Pain Management Drugs & Devices Sales 2019-2030
1.4.3 Global Pain Management Drugs & Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pain Management Drugs & Devices Market Competition by Manufacturers
2.1 Global Pain Management Drugs & Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pain Management Drugs & Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pain Management Drugs & Devices Average Price by Manufacturers (2019-2024)
2.4 Global Pain Management Drugs & Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pain Management Drugs & Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pain Management Drugs & Devices, Product Type & Application
2.7 Pain Management Drugs & Devices Market Competitive Situation and Trends
2.7.1 Pain Management Drugs & Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pain Management Drugs & Devices Players Market Share by Revenue
2.7.3 Global Pain Management Drugs & Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pain Management Drugs & Devices Retrospective Market Scenario by Region
3.1 Global Pain Management Drugs & Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pain Management Drugs & Devices Global Pain Management Drugs & Devices Sales by Region: 2019-2030
3.2.1 Global Pain Management Drugs & Devices Sales by Region: 2019-2024
3.2.2 Global Pain Management Drugs & Devices Sales by Region: 2025-2030
3.3 Global Pain Management Drugs & Devices Global Pain Management Drugs & Devices Revenue by Region: 2019-2030
3.3.1 Global Pain Management Drugs & Devices Revenue by Region: 2019-2024
3.3.2 Global Pain Management Drugs & Devices Revenue by Region: 2025-2030
3.4 North America Pain Management Drugs & Devices Market Facts & Figures by Country
3.4.1 North America Pain Management Drugs & Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pain Management Drugs & Devices Sales by Country (2019-2030)
3.4.3 North America Pain Management Drugs & Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pain Management Drugs & Devices Market Facts & Figures by Country
3.5.1 Europe Pain Management Drugs & Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pain Management Drugs & Devices Sales by Country (2019-2030)
3.5.3 Europe Pain Management Drugs & Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pain Management Drugs & Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Pain Management Drugs & Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pain Management Drugs & Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Pain Management Drugs & Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pain Management Drugs & Devices Market Facts & Figures by Country
3.7.1 Latin America Pain Management Drugs & Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pain Management Drugs & Devices Sales by Country (2019-2030)
3.7.3 Latin America Pain Management Drugs & Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pain Management Drugs & Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Pain Management Drugs & Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pain Management Drugs & Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pain Management Drugs & Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pain Management Drugs & Devices Sales by Type (2019-2030)
4.1.1 Global Pain Management Drugs & Devices Sales by Type (2019-2024)
4.1.2 Global Pain Management Drugs & Devices Sales by Type (2025-2030)
4.1.3 Global Pain Management Drugs & Devices Sales Market Share by Type (2019-2030)
4.2 Global Pain Management Drugs & Devices Revenue by Type (2019-2030)
4.2.1 Global Pain Management Drugs & Devices Revenue by Type (2019-2024)
4.2.2 Global Pain Management Drugs & Devices Revenue by Type (2025-2030)
4.2.3 Global Pain Management Drugs & Devices Revenue Market Share by Type (2019-2030)
4.3 Global Pain Management Drugs & Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pain Management Drugs & Devices Sales by Application (2019-2030)
5.1.1 Global Pain Management Drugs & Devices Sales by Application (2019-2024)
5.1.2 Global Pain Management Drugs & Devices Sales by Application (2025-2030)
5.1.3 Global Pain Management Drugs & Devices Sales Market Share by Application (2019-2030)
5.2 Global Pain Management Drugs & Devices Revenue by Application (2019-2030)
5.2.1 Global Pain Management Drugs & Devices Revenue by Application (2019-2024)
5.2.2 Global Pain Management Drugs & Devices Revenue by Application (2025-2030)
5.2.3 Global Pain Management Drugs & Devices Revenue Market Share by Application (2019-2030)
5.3 Global Pain Management Drugs & Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbvie Inc.
6.1.1 Abbvie Inc. Corporation Information
6.1.2 Abbvie Inc. Description and Business Overview
6.1.3 Abbvie Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbvie Inc. Pain Management Drugs & Devices Product Portfolio
6.1.5 Abbvie Inc. Recent Developments/Updates
6.2 Astrazeneca Depomed Inc.
6.2.1 Astrazeneca Depomed Inc. Corporation Information
6.2.2 Astrazeneca Depomed Inc. Description and Business Overview
6.2.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product Portfolio
6.2.5 Astrazeneca Depomed Inc. Recent Developments/Updates
6.3 Djo Global Inc.
6.3.1 Djo Global Inc. Corporation Information
6.3.2 Djo Global Inc. Description and Business Overview
6.3.3 Djo Global Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Djo Global Inc. Pain Management Drugs & Devices Product Portfolio
6.3.5 Djo Global Inc. Recent Developments/Updates
6.4 Eli Lilly & Co.
6.4.1 Eli Lilly & Co. Corporation Information
6.4.2 Eli Lilly & Co. Description and Business Overview
6.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Product Portfolio
6.4.5 Eli Lilly & Co. Recent Developments/Updates
6.5 Endo International
6.5.1 Endo International Corporation Information
6.5.2 Endo International Description and Business Overview
6.5.3 Endo International Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Endo International Pain Management Drugs & Devices Product Portfolio
6.5.5 Endo International Recent Developments/Updates
6.6 Glaxosmithkline
6.6.1 Glaxosmithkline Corporation Information
6.6.2 Glaxosmithkline Description and Business Overview
6.6.3 Glaxosmithkline Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Glaxosmithkline Pain Management Drugs & Devices Product Portfolio
6.6.5 Glaxosmithkline Recent Developments/Updates
6.7 Hisamitsu Pharmaceutical Co. Inc.
6.6.1 Hisamitsu Pharmaceutical Co. Inc. Corporation Information
6.6.2 Hisamitsu Pharmaceutical Co. Inc. Description and Business Overview
6.6.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product Portfolio
6.7.5 Hisamitsu Pharmaceutical Co. Inc. Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Johnson & Johnson Pain Management Drugs & Devices Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Medtronic Inc.
6.9.1 Medtronic Inc. Corporation Information
6.9.2 Medtronic Inc. Description and Business Overview
6.9.3 Medtronic Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medtronic Inc. Pain Management Drugs & Devices Product Portfolio
6.9.5 Medtronic Inc. Recent Developments/Updates
6.10 Novartis International Ag
6.10.1 Novartis International Ag Corporation Information
6.10.2 Novartis International Ag Description and Business Overview
6.10.3 Novartis International Ag Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis International Ag Pain Management Drugs & Devices Product Portfolio
6.10.5 Novartis International Ag Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Pain Management Drugs & Devices Description and Business Overview
6.11.3 Pfizer Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Pain Management Drugs & Devices Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Purdue Pharmaceuticals Lp
6.12.1 Purdue Pharmaceuticals Lp Corporation Information
6.12.2 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Description and Business Overview
6.12.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product Portfolio
6.12.5 Purdue Pharmaceuticals Lp Recent Developments/Updates
6.13 Abbott
6.13.1 Abbott Corporation Information
6.13.2 Abbott Pain Management Drugs & Devices Description and Business Overview
6.13.3 Abbott Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Abbott Pain Management Drugs & Devices Product Portfolio
6.13.5 Abbott Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pain Management Drugs & Devices Industry Chain Analysis
7.2 Pain Management Drugs & Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pain Management Drugs & Devices Production Mode & Process
7.4 Pain Management Drugs & Devices Sales and Marketing
7.4.1 Pain Management Drugs & Devices Sales Channels
7.4.2 Pain Management Drugs & Devices Distributors
7.5 Pain Management Drugs & Devices Customers
8 Pain Management Drugs & Devices Market Dynamics
8.1 Pain Management Drugs & Devices Industry Trends
8.2 Pain Management Drugs & Devices Market Drivers
8.3 Pain Management Drugs & Devices Market Challenges
8.4 Pain Management Drugs & Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
